CBD shows novel potential to help those addicted to methamphetamine


ENFLEUR is encouraged by a recent study published by the fully peer-reviewed, international Journal of Psychopharmacology investigating the potential of CBD in methamphetamine addiction. Preliminary rodent trials investigated CBD, first, in determining its potential effect on the frequency of use in methamphetamine addiction and, second, in its potential to augment relapse behavior after methamphetamine use has ceased. It found that CBD “reduced the motivation to self-administer” as well as reduced the desire to relapse after ceasing methamphetamine use. This is particularly encouraging as methamphetamine addiction is notoriously destructive for both those who use and their loved ones.

Why does this matter? CBD has been shown to reduce the motivation for methamphetamine in active users as well as to reduce the likelihood of relapse for those in recovery.